ハリコンドリンB (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ハリコンドリンB" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

low place

4,562^nd place

447^th place

1,043^rd place

5,225^th place

low place

clinicaltrials.gov

Hirata Y, Uemura D (1986). “Halichondrins - antitumor polyether macrolides from a marine sponge”. Pure Appl. Chem. 58 (5): 701–710. doi:10.1351/pac198658050701.
Aicher TD, Buszek KR, Fang FG, Forsyth CJ, Jung SH, Kishi Y, Matelich MC, Scola PM, Spero DM, Yoon SK (1992). “Total synthesis of halichondrin B and norhalichondrin B”. J. Am. Chem. Soc. 114 (8): 3162–3164. doi:10.1021/ja00034a086.

"FDA approves new treatment option for late-stage breast cancer" (Press release). USFDA. 15 November 2010. 2010年11月15日閲覧。

アメリカ国立癌研究所 (NCI). “Success Story - Halichondrin B (NSC 609395), E7389 (NSC 707389)” (英語). 2010年10月20日閲覧。
アメリカ国立癌研究所 (NCI). “NCI-60 DTP Human Tumor Cell Line Screen” (英語). 2010年10月20日閲覧。

Bai RL, Paull KD, Herald CL, Malspeis L, Pettit GR, Hamel E (August 1991). “Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data”. J. Biol. Chem. 266 (24): 15882–9. PMID 1874739.
Towle MJ, Salvato KA, Budrow J, Wels BF, Kuznetsov G, Aalfs KK, Welsh S, Zheng W, Seletsk BM, Palme MH, Habgood GJ, Singer LA, Dipietro LV, Wang Y, Chen JJ, Quincy DA, Davis A, Yoshimatsu K, Kishi Y, Yu MJ, Littlefield BA (February 2001). “In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B”. Cancer Res. 61 (3): 1013–21. PMID 11221827.